Our findings showed that CoQ0 upregulated CD24 expression and downregulated CD44 expression in a concentration-dependent manner, shifting the CD24/CD44 ratio in favor of suppressing the cancer stem-like properties of OECM-1 and SAS cells under normoxia and hypoxia. The gene discussed is CD24; the disease is cancer.